{"transactions":[{"id":1478169,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:03:18.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017138","document":"form4-06172024_080614.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017138/form4-06172024_080614.xml","form_type":"4"}},{"id":1850839,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-20T20:07:00.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":11300,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001415889-23-010032","document":"form4-06202023_080655.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010032/form4-06202023_080655.xml","form_type":"4"}},{"id":2229169,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:05:24.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":13600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":13600,"derivative":{"exercise_price":22.48,"exercise_date":"2023-06-16","expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":13600},"source":{"system":"sec-edgar","filing":"0001415889-22-006694","document":"form4-06172022_010651.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588922006694/form4-06172022_010651.xml","form_type":"4"}},{"id":2662443,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-06-21T20:19:56.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":12000,"derivative":{"exercise_price":28,"exercise_date":"2022-06-17","expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001179110-21-006889","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911021006889/edgar.xml","form_type":"4"}},{"id":3104875,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-19T12:03:15.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."}],"balance_after":11000,"derivative":{"exercise_price":10.38,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001179110-20-007586","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911020007586/edgar.xml","form_type":"4"}},{"id":3483500,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-06-20T20:25:58.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."}],"balance_after":4500,"derivative":{"exercise_price":2.78,"exercise_date":"2020-06-19","expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001179110-19-007967","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911019007967/edgar.xml","form_type":"4"}},{"id":3893261,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"Shoos Karen L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-06-15T11:24:08.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":67000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."}],"balance_after":67000,"derivative":{"exercise_price":0.6011,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":67000},"source":{"system":"sec-edgar","filing":"0001179110-18-008556","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911018008556/edgar.xml","form_type":"4"}},{"id":4280103,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"LIPTON KAREN SHOOS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-06-16T13:29:36.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Such option vests in three equal annual installments beginning June 15, 2018."}],"balance_after":15000,"derivative":{"exercise_price":2.32,"exercise_date":"2018-06-15","expiration_date":"2027-06-15","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-17-009165","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009165/edgar.xml","form_type":"4"}},{"id":4280102,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":89857,"kind":"person","name":"Shoos Karen L.","position":1,"cik":"0001255681","reported_name":"LIPTON KAREN SHOOS","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2017-06-16T13:29:36.000Z","date":"2017-06-15","kind":"grant","acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 15, 2017, the Company awarded 10,000 shares of Company common stock as an annual equity grant in the form of restricted stock awards under the Celldex Therapeutics, Inc. 2008 Stock Option Plan subject to time-based forfeiture restrictions."}],"balance_after":41833,"source":{"system":"sec-edgar","filing":"0001179110-17-009165","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000117911017009165/edgar.xml","form_type":"4"}}]}